In a vast two-stage genome-wide association study of varicose veins in 401,656 individuals from UK Biobank, and replication in 408,969 individuals from 23andMe, Oxford researchers identified 49 genetic variants that increase the risk of varicose veins. They highlighted pathways including problems with the connective tissues of the body, and the immune system as key players in varicose vein pathology.
This study was an interdisciplinary collaborative effort across the Medical Sciences Division at the University of Oxford. Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, the Nuffield Department of Surgical Sciences and the Nuffield Department of Women's & Reproductive Health worked with an American commercial, direct to consumer genotyping company called 23andMe to explore which people were more susceptible to developing Varicose veins.
Lead author Prof Dominic Furniss commented:
"The inclusion of surgeons in the research team was vital as they enabled the identification of patients whose disease was more severe, and they had therefore had surgery. This lead to the discovery of 49 genetic variants at 46 areas into the genome that predisposes to Varicose veins. This breakthrough greatly improves our team's knowledge of the biology of Varicose veins, and it will be the foundation of further research into the biology and potentially new treatment".
Co-author Prof Krina Zondervan said:
“This large study brings together a great deal of new evidence of the genetics underlying varicose veins, a condition that is highly prevalent in women and in pregnancy. It opens up exciting new avenues for the development of new future treatments.”
You can read the study "Genome-wide association analysis and replication in 810,625 individuals with varicose veins" published in Nature Communications here.